emerging psychoactive substances

Use of synthetic cannabis has halved among a group of regular stimulant drug users and use of other synthetic drugs appears to have stabilised, a national drugs trends conference will hear today.

Drugs and New Technologies (DNeT)

The Drugs and New Technologies (DNeT) project aims to investigate drug marketplaces online and in other emerging technologies. It aims to assess and quantify the online availability of drugs, including both traditional and new psychoactive substances.

Project Status:

Current

Bureaucrats, beagles and backlash: What can we learn about a regulated “legal high” market 3 months into New Zealand’s novel approach?

Category:

International Drug

Event date:

Friday, 15 November 2013 - 11:00am

Event Type:

Lecture

Ross Bell, Executive Director of the New Zealand Drug Foundation, will provide an update about New Zealand’s world-first attempt to regulate New Psychoactive Substances.

Experts deliver warning on emerging psychoactive substances (EPS) and hallucinogens

Date Published:

Tuesday, 15 October 2013

Four out of 10 regular psychostimulant users have used an EPS in the past six months
Frequency of use remains low – one or two occasions in six months
Some users seeking out hallucinogens, but many take them inadvertently

First findings from internet drug monitoring program

Date Published:

Thursday, 1 August 2013

The National Drug and Alcohol Research Centre (NDARC) has today published findings from a new research stream dedicated to tracking the internet’s increasing role in the supply of illicit drugs and drug-related information.

Ignorance about potentially harmful and addictive new psychoactive drugs raises public health concerns

Date Published:

Wednesday, 16 November 2011

This media release was first issued by Moore Public Relations on behalf of the Australian Professional Society on Alcohol and other Drugs (APSAD).